Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 1—global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster Virus anterior uveitis

Abstract

Aims

To present current expert practice patterns and to formulate a consensus for the management of HSV and VZV AU by uveitis specialists worldwide.

Methods

A two-round online modified Delphi survey with masking of the study team was conducted. Responses were collected from 76 international uveitis experts from 21 countries. Current practices in the diagnosis and treatment of HSV and VZV AU were identified. A working group (The Infectious Uveitis Treatment Algorithm Network [TITAN]) developed data into consensus guidelines. Consensus is defined as a particular response towards a specific question meeting ≥75% of agreement or IQR ≤ 1 when a Likert scale is used.

Results

Unilaterality, increased intraocular pressure (IOP), decreased corneal sensation and diffuse or sectoral iris atrophy are quite specific for HSV or VZV AU from consensus opinion. Sectoral iris atrophy is characteristic of HSV AU. Treatment initiation is highly variable, but most experts preferred valacyclovir owing to simpler dosing. Topical corticosteroids and beta-blockers should be used if necessary. Resolution of inflammation and normalisation of IOP are clinical endpoints.

Conclusions

Consensus was reached on several aspects of diagnosis, choice of initial treatment, and treatment endpoints for HSV and VZV AU. Treatment duration and management of recurrences varied between experts.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Proposed management algorithm for suspected HSV/VZV AU.

Similar content being viewed by others

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author upon reasonable request.

References

  1. Rathinam SR, Namperumalsamy P. Global variation and pattern changes in epidemiology of uveitis. Indian J Ophthalmol. 2007;55:173–83.

    Article  PubMed  CAS  Google Scholar 

  2. Siverio Júnior CD, Imai Y, Cunningham ETJ. Diagnosis and management of herpetic anterior uveitis. Int Ophthalmol Clin. 2002;42:43–8.

    Article  PubMed  Google Scholar 

  3. Zandi S, Bodaghi B, Garweg JG. Review for disease of the year: treatment of viral anterior uveitis: a perspective. Ocul Immunol Inflamm. 2018;26:1135–42.

    Article  PubMed  CAS  Google Scholar 

  4. Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26:2–16.

    Article  PubMed  Google Scholar 

  5. Chee S-P, Jap A. Viral anterior uveitis. In: Biswas J, Majumder PD, editors. Uveitis: an update. New Delhi: Springer; 2016.

    Google Scholar 

  6. Abdulaal MR, Abiad BH, Hamam RN. Uveitis in the aging eye: incidence, patterns, and differential diagnosis. J Ophthalmol. 2015;2015:509456.

    PubMed  PubMed Central  Google Scholar 

  7. Sakai J-I, Usui Y, Suzuki J, Kezuka T, Goto H. Clinical features of anterior uveitis caused by three different herpes viruses. Int Ophthalmol. 2019;39:2785–95.

    Article  PubMed  Google Scholar 

  8. Takase H, Kubono R, Terada Y, Imai A, Fukuda S, Tomita M, et al. Comparison of the ocular characteristics of anterior uveitis caused by herpes simplex virus, varicella-zoster virus, and cytomegalovirus. Jpn J Ophthalmol. 2014;58:473–82.

    Article  PubMed  CAS  Google Scholar 

  9. Chronopoulos A, Roquelaure D, Souteyrand G, Seebach JD, Schutz JS, Thumann G. Aqueous humor polymerase chain reaction in uveitis—utility and safety. BMC Ophthalmol. 2016;16:1–7.

    Article  Google Scholar 

  10. Wensing B, Mochizuki M, De Boer JH. Clinical characteristics of herpes simplex virus associated anterior uveitis. Ocul Immunol Inflamm. 2018;26:333–37.

    Article  PubMed  Google Scholar 

  11. Neumann R, Barequet D, Rosenblatt A, Amer R, Ben-Arie-Weintrob Y, Hareuveni-Blum T, et al. Herpetic anterior uveitis—analysis of presumed and PCR proven cases. Ocul Immunol Inflamm. 2019;27:211–18.

    Article  PubMed  CAS  Google Scholar 

  12. Qian Z, Fan H, Tao Y, Li W, Gu W. Herpetic anterior uveitis in a Chinese referral center: clinical manifestations and laboratory test results. Ocul Immunol Inflamm. 2020;28:758–63.

    Article  PubMed  CAS  Google Scholar 

  13. Testi I, Aggarwal K, Jaiswal N, Dahiya N, Thng ZX, Agarwal A, et al. Antiviral therapy for Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV)-induced anterior uveitis: a systematic review and meta-analysis. Front Med. 2021;8:686427.

    Article  Google Scholar 

  14. Kalezic T, Mazen M, Kuklinski E, Asbell P. Herpetic eye disease study: lessons learned. Curr Opin Ophthalmol. 2018;29:340–46.

    Article  PubMed  Google Scholar 

  15. Anon. A controlled trial of oral acyclovir for iridocyclitis caused by herpes simplex virus. The Herpetic Eye Disease Study Group. Arch Ophthalmol. 1996;114:1065–72.

    Article  Google Scholar 

  16. Centre for Evidence-Based Medicine. Oxford Centre for Evidence-Based Medicine—levels of evidence. 2009. http://www.cebm.net/oxford-centre-evidence-based-medicine-levels-evidence-march-2009/.

  17. Niederberger M, Köberich S. Coming to consensus: the Delphi technique. Eur J Cardiovasc Nurs. 2021;20:692–95.

    Article  PubMed  Google Scholar 

  18. Nasa P, Jain R, Juneja D. Delphi methodology in healthcare research: how to decide its appropriateness. World J Methodol. 2021;11:116–29.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Radosavljevic A, Agarwal M, Chee SP, Zierhut M. Epidemiology of viral induced anterior uveitis. Ocul Immunol Inflamm. 2022;30:297–309.

    Article  PubMed  Google Scholar 

  20. Keorochana N, Treesit I, Funarunart P. Characteristics and clinical outcomes of hypertensive anterior uveitis. Ocul Immunol Inflamm. 2020;28:538–48.

    Article  PubMed  CAS  Google Scholar 

  21. Accorinti M, Petitti L, Gaeta A, Giannini D, De Geronimo D. Viral acute anterior uveitis: clinical signs useful for differential diagnosis. Ocul Immunol Inflamm. 2020;29:1355–62.

    Article  PubMed  Google Scholar 

  22. Groen-Hakan F, Babu K, Tugal-Tutkun I, Pathanapithoon K, de Boer JH, Smith JR, et al. Challenges of diagnosing viral anterior uveitis. Ocul Immunol Inflamm. 2017;25:710–20.

    Article  PubMed  Google Scholar 

  23. Choi W, Kang HG, Choi EY, Kim SS, Kim CY, Koh HJ, et al. Clinical utility of aqueous humor polymerase chain reaction and serologic testing for suspected infectious uveitis: a single-center retrospective study in South Korea. BMC Ophthalmol. 2020;20:242.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. De Groot-Mijnes JDF, Chan ASY, Chee SP, Verjans GMGM. Immunopathology of virus-induced anterior uveitis. Ocul Immunol Inflamm. 2018;26:338–46.

    Article  PubMed  Google Scholar 

  25. Pleyer U, Chee S-P. Current aspects on the management of viral uveitis in immunocompetent individuals. Clin Ophthalmol. 2015;9:1017–28.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Yoo W-S, Kim G-N, Chung I, Cho M-C, Han YS, Kang SS, et al. Clinical characteristics and prognostic factors in hypertensive anterior uveitis diagnosed with polymerase chain reaction. Sci Rep. 2021;11:8814.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  27. Kongyai N, Sirirungsi W, Pathanapitoon K, Tananuvat N, Kunavisarut P, Leechanachai P, et al. Viral causes of unexplained anterior uveitis in Thailand. Eye. 2012;26:529–34.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. van Velzen M, Missotten T, van Loenen FB, Meesters RJW, Luider TM, Baarsma GS, et al. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients. J Clin Virol. 2013;57:215–21.

    Article  PubMed  Google Scholar 

  29. Neoh C, Harding SP, Saunders D, Wallis S, Tullo AB, Nylander A, et al. Comparison of topical and oral acyclovir in early herpes zoster ophthalmicus. Eye. 1994;8:688–91.

    Article  PubMed  Google Scholar 

  30. Beutner KR. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antivir Res. 1995;28:281–90.

    Article  PubMed  CAS  Google Scholar 

  31. Miserocchi E, Modorati G, Galli L, Rama P. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Am J Ophthalmol. 2007;144:547–51.

    Article  PubMed  CAS  Google Scholar 

  32. Schuster AK, Harder BC, Schlichtenbrede FC, Jarczok MN, Tesarz J. Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients. Cochrane Database Syst Rev. 2016;11:CD11503.

    Google Scholar 

  33. Gershon AA, Breuer J, Cohen JI, Cohrs RJ, Gershon MD, Gilden D, et al. Varicella zoster virus infection. Nat Rev Dis Prim. 2015;1:15016.

    Article  PubMed  Google Scholar 

  34. Sung VCT, Barton K. Management of inflammatory glaucomas. Curr Opin Ophthalmol. 2004;15:136–40.

    Article  PubMed  Google Scholar 

  35. Chang JH, McCluskey P, Missotten T, Ferrante P, Jalaludin B, Lightman S. Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema? Br J Ophthalmol. 2008;92:916–21.

    Article  PubMed  CAS  Google Scholar 

  36. Markomichelakis NN, Kostakou A, Halkiadakis I, Chalkidou S, Papakonstantinou D, Georgopoulos G. Efficacy and safety of latanoprost in eyes with uveitic glaucoma. Graefes Arch Clin Exp Ophthalmol. 2009;247:775–80.

    Article  PubMed  CAS  Google Scholar 

  37. Chan NS-W, Ti S-E, Chee S-P. Decision-making and management of uveitic cataract. Indian J Ophthalmol. 2017;65:1329–39.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

HNS’s work is supported by the NIH Intramural Research Program (IRP). The funding organisation had no role in the design or conduct of this research. RA has received NMRC Clinician Scientist Award from National Medical Research Council, Singapore, but the funding organisation has no role in the design or conduct of this research.

Author information

Authors and Affiliations

Authors

Consortia

Contributions

All authors contributed to the intellectual development of this paper. RA and VG conceived and planned the study. ZXT and IP wrote the first draft of the paper. ZXT, IP, IT, and KC performed the literature review. ZXT, IP, IT, KC, MW, SPC, ADD, JHK, BB, JET, TBA, MDdS, JRS, PM, RLDN, DAJ, JHdB, HNS, DAG, MK, JLD, JTR, NPJ, QDN, CP, RA, and VG contributed to interpreting the results and provided critical feedback to the paper. The final version of the paper has been seen and approved by all authors.

Corresponding authors

Correspondence to Rupesh Agrawal or Vishali Gupta.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Thng, Z.X., Putera, I., Testi, I. et al. The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 1—global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster Virus anterior uveitis. Eye 38, 61–67 (2024). https://doi.org/10.1038/s41433-023-02630-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41433-023-02630-9

Search

Quick links